Group 7 Copy 3 Created with Sketch.

MENU
Centers
Carotid Coding Dialysis Embolization EVAR HTN Limb Salvage Neurointervention Oncology Radial Regulatory Renal SFA TEVAR Venous
News Current Issue Archive Device Guide Calendar Subscribe Advertising About Contact Privacy Submissions

Advertisement

Search Results

Refine by Content Type

close Created with Sketch.

Refine by Year

close Created with Sketch.

Sort By:

Relevance Date

Choose Sites to Search:

EVToday EVToday + CIToday

evt | Article | September 2003

The NEPHRIC Trial

This prospective, randomized trial demonstrates the superiority of iodixanol to low-osmolar contrast media in preventing contrast-induced nephropathy.

By Adam Brodsky, MD, and Charles J. Davidson, MD

evt | News | October 13, 2011

PLC's US Pivotal Study of RenalGuard Approved

October 14, 2011—PLC Medical Systems, Inc. (Milford, MA) announced that it has received final approval from the US Food and Drug Administration to commence its United States pivotal trial to study the efficacy of the company's RenalGuard therapy and RenalGuard system for the prevention of contrast-induced nephropathy.

evt | News | January 22, 2012

US Pivotal Trial of PLC's RenalGuard Begins Enrollment

January 23, 2012—PLC Medical Systems, Inc. (Milford, MA) announced the start of enrollment in the CINRG trial, the company's pivotal trial in the United States to study the efficacy of its RenalGuard Therapy and RenalGuard System in the prevention of contrastinduced nephropathy (CIN).

evt | News | January 22, 2012

US Pivotal Trial of PLC's RenalGuard Begins Enrollment

January 23, 2012—PLC Medical Systems, Inc. (Milford, MA) announced the start of enrollment in the CIN-RG trial, the company's pivotal trial in the United States to study the efficacy of its RenalGuard Therapy and RenalGuard System in the prevention of contrast-induced nephropathy (CIN).

Advertisement

Advertisement

Cardiac Interventions Today
Group 7 Copy 3 Created with Sketch.
bmc-secondary-mark-color copy Created with Sketch.

© 2026 Bryn Mawr Communications II, LLC.  
All Rights Reserved   •   Privacy Policy

one-trust-button